View in EDS HTML Full Text PDF Full Text

Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure.

Saved in:
Bibliographic Details
Title: Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure.
Authors: Merrill MH; Department of Medicine University of California, San Francisco San Francisco California United States., Redd RA; Department of Medical Oncology Dana-Farber Cancer Institute Boston Massachusetts United States., Lambert N; Department of Medicine Baylor College of Medicine Houston Texas United States., Caimi PF; Department of Hematology and Medical Oncology, Taussig Cancer Institute Cleveland Clinic Foundation Cleveland Ohio United States., Pullarkat P; Division of Hematology-Oncology Massachusetts General Hospital Boston Massachusetts United States., Godby RC; Hematology Division Mayo Clinic Rochester Minnesota United States., Bond DA; Division of Hematology, The James Cancer Hospital and Solove Research Institute The Ohio State University Columbus Ohio United States., Wehmeyer GT; Department of Medicine, Meyer Cancer Center Weill Cornell Medicine and New York Presbyterian Hospital New York New York United States., Romancik J; Department of Hematology and Medical Oncology Winship Cancer Institute at Emory University Atlanta Georgia United States., Amoozgar B; Department of Medicine Washington University School of Medicine St. Louis Missouri United States., Leslie L; Lymphoma Division, John Theurer Cancer Center Hackensack Meridian Health Hackensack New Jersey United States., Nastoupil LJ; Department of Lymphoma and Myeloma M.D. Anderson Cancer Center Houston Texas United States., Crombie JL; Department of Medical Oncology Dana-Farber Cancer Institute Boston Massachusetts United States., Abramson JS; Division of Hematology-Oncology Massachusetts General Hospital Boston Massachusetts United States., Khurana A; Hematology Division Mayo Clinic Rochester Minnesota United States., Nowakowski GS; Hematology Division Mayo Clinic Rochester Minnesota United States., Maddocks K; Division of Hematology, The James Cancer Hospital and Solove Research Institute The Ohio State University Columbus Ohio United States., Rutherford SC; Department of Medicine, Meyer Cancer Center Weill Cornell Medicine and New York Presbyterian Hospital New York New York United States., Kahl B; Department of Medicine Washington University School of Medicine St. Louis Missouri United States., Okwali M; Lymphoma Service, Division of Hematologic Malignancies Memorial Sloan Kettering Cancer Center New York New York United States., Buege MJ; Department of Pharmacy Practice University of Illinois Chicago College of Pharmacy Chicago Illinois United States., Batlevi CL; Genentech Inc. South San Francisco California United States., Armand P; Department of Medical Oncology Dana-Farber Cancer Institute Boston Massachusetts United States., Salles G; Lymphoma Service, Division of Hematologic Malignancies Memorial Sloan Kettering Cancer Center New York New York United States.; Department of Medicine Weill Cornell Medical College New York New York United States., Qualls DA; Department of Medical Oncology Dana-Farber Cancer Institute Boston Massachusetts United States.
Source: HemaSphere [Hemasphere] 2025 Nov 18; Vol. 9 (11), pp. e70253. Date of Electronic Publication: 2025 Nov 18 (Print Publication: 2025).
Publication Type: Letter
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41262124
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Merrill+MH%22">Merrill MH</searchLink>; Department of Medicine University of California, San Francisco San Francisco California United States.<br /><searchLink fieldCode="AU" term="%22Redd+RA%22">Redd RA</searchLink>; Department of Medical Oncology Dana-Farber Cancer Institute Boston Massachusetts United States.<br /><searchLink fieldCode="AU" term="%22Lambert+N%22">Lambert N</searchLink>; Department of Medicine Baylor College of Medicine Houston Texas United States.<br /><searchLink fieldCode="AU" term="%22Caimi+PF%22">Caimi PF</searchLink>; Department of Hematology and Medical Oncology, Taussig Cancer Institute Cleveland Clinic Foundation Cleveland Ohio United States.<br /><searchLink fieldCode="AU" term="%22Pullarkat+P%22">Pullarkat P</searchLink>; Division of Hematology-Oncology Massachusetts General Hospital Boston Massachusetts United States.<br /><searchLink fieldCode="AU" term="%22Godby+RC%22">Godby RC</searchLink>; Hematology Division Mayo Clinic Rochester Minnesota United States.<br /><searchLink fieldCode="AU" term="%22Bond+DA%22">Bond DA</searchLink>; Division of Hematology, The James Cancer Hospital and Solove Research Institute The Ohio State University Columbus Ohio United States.<br /><searchLink fieldCode="AU" term="%22Wehmeyer+GT%22">Wehmeyer GT</searchLink>; Department of Medicine, Meyer Cancer Center Weill Cornell Medicine and New York Presbyterian Hospital New York New York United States.<br /><searchLink fieldCode="AU" term="%22Romancik+J%22">Romancik J</searchLink>; Department of Hematology and Medical Oncology Winship Cancer Institute at Emory University Atlanta Georgia United States.<br /><searchLink fieldCode="AU" term="%22Amoozgar+B%22">Amoozgar B</searchLink>; Department of Medicine Washington University School of Medicine St. Louis Missouri United States.<br /><searchLink fieldCode="AU" term="%22Leslie+L%22">Leslie L</searchLink>; Lymphoma Division, John Theurer Cancer Center Hackensack Meridian Health Hackensack New Jersey United States.<br /><searchLink fieldCode="AU" term="%22Nastoupil+LJ%22">Nastoupil LJ</searchLink>; Department of Lymphoma and Myeloma M.D. Anderson Cancer Center Houston Texas United States.<br /><searchLink fieldCode="AU" term="%22Crombie+JL%22">Crombie JL</searchLink>; Department of Medical Oncology Dana-Farber Cancer Institute Boston Massachusetts United States.<br /><searchLink fieldCode="AU" term="%22Abramson+JS%22">Abramson JS</searchLink>; Division of Hematology-Oncology Massachusetts General Hospital Boston Massachusetts United States.<br /><searchLink fieldCode="AU" term="%22Khurana+A%22">Khurana A</searchLink>; Hematology Division Mayo Clinic Rochester Minnesota United States.<br /><searchLink fieldCode="AU" term="%22Nowakowski+GS%22">Nowakowski GS</searchLink>; Hematology Division Mayo Clinic Rochester Minnesota United States.<br /><searchLink fieldCode="AU" term="%22Maddocks+K%22">Maddocks K</searchLink>; Division of Hematology, The James Cancer Hospital and Solove Research Institute The Ohio State University Columbus Ohio United States.<br /><searchLink fieldCode="AU" term="%22Rutherford+SC%22">Rutherford SC</searchLink>; Department of Medicine, Meyer Cancer Center Weill Cornell Medicine and New York Presbyterian Hospital New York New York United States.<br /><searchLink fieldCode="AU" term="%22Kahl+B%22">Kahl B</searchLink>; Department of Medicine Washington University School of Medicine St. Louis Missouri United States.<br /><searchLink fieldCode="AU" term="%22Okwali+M%22">Okwali M</searchLink>; Lymphoma Service, Division of Hematologic Malignancies Memorial Sloan Kettering Cancer Center New York New York United States.<br /><searchLink fieldCode="AU" term="%22Buege+MJ%22">Buege MJ</searchLink>; Department of Pharmacy Practice University of Illinois Chicago College of Pharmacy Chicago Illinois United States.<br /><searchLink fieldCode="AU" term="%22Batlevi+CL%22">Batlevi CL</searchLink>; Genentech Inc. South San Francisco California United States.<br /><searchLink fieldCode="AU" term="%22Armand+P%22">Armand P</searchLink>; Department of Medical Oncology Dana-Farber Cancer Institute Boston Massachusetts United States.<br /><searchLink fieldCode="AU" term="%22Salles+G%22">Salles G</searchLink>; Lymphoma Service, Division of Hematologic Malignancies Memorial Sloan Kettering Cancer Center New York New York United States.; Department of Medicine Weill Cornell Medical College New York New York United States.<br /><searchLink fieldCode="AU" term="%22Qualls+DA%22">Qualls DA</searchLink>; Department of Medical Oncology Dana-Farber Cancer Institute Boston Massachusetts United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101740619%22">HemaSphere</searchLink> [Hemasphere] 2025 Nov 18; Vol. 9 (11), pp. e70253. <i>Date of Electronic Publication: </i>2025 Nov 18 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101740619 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2572-9241 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225729241%22">25729241 </searchLink><i>NLM ISO Abbreviation: </i>Hemasphere <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41262124
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/hem3.70253
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e70253
    Titles:
      – TitleFull: Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Merrill MH
      – PersonEntity:
          Name:
            NameFull: Redd RA
      – PersonEntity:
          Name:
            NameFull: Lambert N
      – PersonEntity:
          Name:
            NameFull: Caimi PF
      – PersonEntity:
          Name:
            NameFull: Pullarkat P
      – PersonEntity:
          Name:
            NameFull: Godby RC
      – PersonEntity:
          Name:
            NameFull: Bond DA
      – PersonEntity:
          Name:
            NameFull: Wehmeyer GT
      – PersonEntity:
          Name:
            NameFull: Romancik J
      – PersonEntity:
          Name:
            NameFull: Amoozgar B
      – PersonEntity:
          Name:
            NameFull: Leslie L
      – PersonEntity:
          Name:
            NameFull: Nastoupil LJ
      – PersonEntity:
          Name:
            NameFull: Crombie JL
      – PersonEntity:
          Name:
            NameFull: Abramson JS
      – PersonEntity:
          Name:
            NameFull: Khurana A
      – PersonEntity:
          Name:
            NameFull: Nowakowski GS
      – PersonEntity:
          Name:
            NameFull: Maddocks K
      – PersonEntity:
          Name:
            NameFull: Rutherford SC
      – PersonEntity:
          Name:
            NameFull: Kahl B
      – PersonEntity:
          Name:
            NameFull: Okwali M
      – PersonEntity:
          Name:
            NameFull: Buege MJ
      – PersonEntity:
          Name:
            NameFull: Batlevi CL
      – PersonEntity:
          Name:
            NameFull: Armand P
      – PersonEntity:
          Name:
            NameFull: Salles G
      – PersonEntity:
          Name:
            NameFull: Qualls DA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 11
              Text: 2025 Nov 18
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2572-9241
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: HemaSphere
              Type: main
ResultId 1